This is Vol. 15 of the WHO International Histological Classification of Tumours. These volumes have appeared over the past 10 years, and enough have now been published for the quality and scope of the project to be apparent. These are not textbooks or monographs; their aim is to promote an internationally agreed terminology and classification of human tumour types. Essentially they are collections of colour photomicrographs of sections, stained by conventional methods, with a scheme of classification and brief explanatory notes. The importance of achieving an agreed nomenclature for epidemiological purposes or for organizing clinical trials is obvious. These volumes are also of great value to diagnostic histopathologists, specially to those without ready access to specialized reference laboratories. Armed with these volumes, and the U.S. Armed Forces Institute of Pathology's Atlas of Tumor Pathology, the histopathologist should be able to cope effectively with most of the diagnostic problems presented by human neoplasia. Both sets are essential items for the diagnostic laboratory.
This volume on intestinal tumours comes from St Mark's Hospital, London, and has all the merits one expects from that renowned centre. This is, in fact, one of the best of the volumes so far in this series. The regions covered are the small intestine, appendix, large intestine, anal canal and anal margin. As well as tumours, valuable sections are devoted to the tumour-like lesions, so often a source of diagnostic difficulty in these regions. Not everyone will agree with the details of the classification adopted, but pathologists should be encouraged to give it a trial. The explanatory notes are brief and pithy. The microphotographs are all of excellent quality and superbly reproduced. Bleomycin (BLM), an anticancer antibiotic was discovered in Japan by Umezawa and his colleagues in 1959 and has been the subject of much experimental and clinical research since that time. It is appropriate therefore that this monograph should be published on behalf of the Japaneze Cancer Association to summarise the data. Unfortunately, as is usual in such books, it is already partially out of date, but it still remains the best on the subject.
The first 96 pages, devoted to fundamental aspects, are the most consistently good. These contain an excellent introduction by Umezawa on the history, chemistry and action of the drug. Its pattern of binding and reaction with DNA and the variable inactivation of the drug in different tissues and tumours go a long wxNay to explain some of its unique features, in particular its action on squamous-cell tissue and tumours. Two other chapters in the section by Japanese and German wrorkers amplify some aspects of this problem.
The remaining part of the section on fundamental aspects is concerned w ith its action in terms of cell kinetics. Terasima and Barranco with their colleagues provide twro useful but slightly outdated chapters in which features of repair, phase specificity, resistance and use as a synchronizing agent are discussed.
The remainder of the book is devoted to clinical subjects. The most noticeable of these is the excellent review by Shanta and
